Brooks O'Neil
Stock Analyst at Lake Street
(0.77)
# 3,633
Out of 4,814 analysts
35
Total ratings
26.47%
Success rate
-23.23%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRDX Surmodics | Upgrades: Buy | $43 | $27.67 | +55.40% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $86.28 | +27.49% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $11.18 | +168.34% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $34.40 | +106.40% | 1 | Jan 24, 2025 | |
| MODV ModivCare | Maintains: Buy | $30 → $10 | $0.96 | +938.75% | 3 | Jan 13, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $20 → $14 | $9.21 | +52.01% | 6 | Jan 8, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $13.42 | +93.74% | 1 | Dec 19, 2024 | |
| LFMD LifeMD | Initiates: Buy | $12 | $5.10 | +135.53% | 1 | Dec 10, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $23.96 | +129.60% | 3 | Oct 4, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $32 → $18 | $10.54 | +70.86% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $4.21 | +18.76% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $75 | $16.86 | +344.97% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $4.5 | $9.24 | -51.30% | 1 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $6.69 | +79.37% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $22.65 | +14.79% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $2.33 | +1,831.33% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.86 | +1,178.92% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $29.98 | +325.28% | 1 | Sep 15, 2020 |
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $27.67
Upside: +55.40%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $86.28
Upside: +27.49%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $11.18
Upside: +168.34%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $34.40
Upside: +106.40%
ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $0.96
Upside: +938.75%
AVITA Medical
Jan 8, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $9.21
Upside: +52.01%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $13.42
Upside: +93.74%
LifeMD
Dec 10, 2024
Initiates: Buy
Price Target: $12
Current: $5.10
Upside: +135.53%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $23.96
Upside: +129.60%
Alphatec Holdings
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $10.54
Upside: +70.86%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $4.21
Upside: +18.76%
May 22, 2024
Maintains: Buy
Price Target: $60 → $75
Current: $16.86
Upside: +344.97%
Mar 14, 2024
Maintains: Buy
Price Target: $9 → $4.5
Current: $9.24
Upside: -51.30%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $6.69
Upside: +79.37%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $22.65
Upside: +14.79%
Nov 21, 2022
Assumes: Buy
Price Target: $45
Current: $2.33
Upside: +1,831.33%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.86
Upside: +1,178.92%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $29.98
Upside: +325.28%